Five Arrows Managers
Five Arrows is the alternative assets arm of Rothschild & Co, founded in 2008 and headquartered in Paris, France. It manages over €31 billion in assets across corporate and secondary private equity, multi-manager funds, co-investments, and credit strategies, focusing on mid-market companies in Europe and North America.
Key facts
Recent exits
Coverage notes
5 funds tracked, 56 portfolio companies (37 active · 19 realized). Verified weekly from public filings and deal announcements.
Sector breakdown
56 companiesFunds & portfolio
Every fund Five Arrows Managers has raised, with its portfolio companies. Hand-checked from public filings.
Five Arrows Debt Partners IVPrivate Debt2025 · 1yr€2.4B3 active
Five Arrows Secondary Opportunities VISecondaries2025 · 1yr€2.0B0 active
No portfolio companies tracked yet.
Five Arrows Principal InvestmentsGrowth2024 · 2yr€1.3B32 active · 17 realized
Unrealized
32 held| Company | Sector | Geo | Entry |
|---|---|---|---|
| Data & Analytics |  France | 2017 | |
| HealthTech |  UK | 2024 | |
| Financials |  Netherlands | 2024 | |
| Business Services |  US | 2019 | |
| HealthTech | US | 2025 | |
| TMT | US | 2021 | |
| TMT | UK | 2021 | |
| Healthcare | Republic Of Ireland | 2024 | |
| TMT | UK | 2024 | |
| TMT | UK | 2022 | |
| TMT | France | 2022 | |
| TMT | France | 2025 | |
| Business Services | France | 2024 | |
| TMT |  Austria | 2024 | |
| Telecom | France | 2022 | |
| TMT | US | 2020 | |
| TMT |  Sweden | 2024 | |
| TMT | US | 2025 | |
| MedTech | France | 2017 | |
| PropTech | US | 2025 | |
| TMT | UK | 2024 | |
| TMT | Netherlands | 2021 | |
Photonis | Business Services | France | 2024 |
| Healthcare |  Germany | 2019 | |
| TMT | US | 2024 | |
| TMT | US | 2015 | |
| MedTech |  Ireland | 2024 | |
| TMT | UK | 2024 | |
| TMT | UK | 2024 | |
| TMT | US | 2024 | |
| Pharma | UK | 2021 | |
| Business Services | US | 2024 |
France· Entry 2017UK· Entry 2024Netherlands· Entry 2024US· Entry 2019US· Entry 2025US· Entry 2021UK· Entry 2021UK· Entry 2024UK· Entry 2022France· Entry 2022France· Entry 2025France· Entry 2024Austria· Entry 2024France· Entry 2022US· Entry 2020Sweden· Entry 2024US· Entry 2025France· Entry 2017US· Entry 2025UK· Entry 2024Netherlands· Entry 2021France· Entry 2024Germany· Entry 2019US· Entry 2024US· Entry 2015Ireland· Entry 2024UK· Entry 2024UK· Entry 2024US· Entry 2024UK· Entry 2021US· Entry 2024Realized
17 exits| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Business Services | UK | 2014 | 2017 | Trade Sale | – | ||
| TMT | France | 2018 | 2023 | Secondary | – | ||
| Business Services |  Spain | 2010 | 2021 | Secondary | – | ||
| Real Estate | France | 2011 | 2018 | Secondary | – | ||
| Consumer |  Italy | 2014 | 2018 | Secondary | – | ||
| Fintech | France | 2019 | 2024 | Secondary | – | ||
| Consumer | France | 2016 | 2022 | Secondary | – | ||
| Real Estate | UK | 2011 | 2017 | Secondary | – | ||
| Business Services | France | 2010 | 2016 | Secondary | – | ||
| Energy | Sweden | 2011 | 2017 | IPO | – | ||
| TMT | UK | 2015 | 2019 | Secondary | – | ||
| Consumer | France | 2011 | 2017 | Secondary | – | ||
| TMT | Germany | 2014 | 2018 | Secondary | – | ||
| Healthcare | France | 2013 | 2019 | Secondary | – | ||
| HealthTech | France | 2020 | 2025 | Secondary | – | ||
| MedTech | UK | 2011 | 2023 | Trade Sale | – | ||
| Healthcare | US | 2017 | 2021 | Secondary | – |
Five Arrows Growth CapitalGrowth2022 · 4yr€78M2 active · 1 realized
Unrealized
2 held
BelgiumFive Arrows Direct LendingPrivate Debt2014 · 12yr€100M0 active · 1 realized
Realized
1 exit| Company | Sector | Geo | Entry | Exit | Type | Buyer | MOIC |
|---|---|---|---|---|---|---|---|
| Healthcare | France | 2013 | 2020 | Secondary | – |
Saved GPs appear in your watchlist, one click from your workspace.
About Five Arrows Managers
Five Arrows is the alternative assets arm of Rothschild & Co, founded in 2008 and headquartered in Paris with €31 billion of assets under management across corporate and secondary private equity, multi-manager funds, co-investments and credit strategies. The platform leverages the multi-century Rothschild banking heritage to provide diversified alternative asset management across multiple distinct strategy categories.
Investment thesis
Five Arrows deploys capital across complementary alternative strategies including corporate private equity (mid-market buyout and growth), secondary private equity (LP-led and GP-led secondary transactions), multi-manager funds (fund-of-funds positions), co-investments alongside lead sponsors, and credit strategies (private debt and credit secondaries). The multi-strategy mandate enables Five Arrows to provide institutional limited partners with diversified European alternative asset exposure.
Recent activity
Recent realised exits include Softway Medical (healthcare, 2025), Harvest (financials, 2024) and Menix Group (healthcare, 2024), reflecting strong distribution across the multi-strategy alternative platform. The platform tracks 3 funds tracked on GP Intel, 32 active portfolio companies and 21 realised exits across the broader Five Arrows alternative asset programme. Detailed buyer names and multiple data available on Pro at €29/month.
Similar firms
Other private equity firms tracked on GP Intel.
France·€30M
France·€30M
France·€35M
France·€35M
France·€35MFrance·€25M
France·€25M
France·€20M
France·€20M
France·€44M
France·€45M
France·€48MGet the full picture on Five Arrows Managers.
Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.
Already a member? Sign in